Lucas Ward
Stock Analyst at Ascendiant Capital
(0.73)
# 3,843
Out of 4,876 analysts
17
Total ratings
35.29%
Success rate
-35.39%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $1.71 | +110.53% | 5 | Jun 16, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $5.8 → $7 | $2.30 | +204.35% | 2 | Jun 2, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $3.28 | +89.02% | 3 | Apr 15, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.67 | +281.47% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.27 | +6,516.23% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $7.21 | +37,347.99% | 2 | Jul 29, 2024 |
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $1.71
Upside: +110.53%
60 Degrees Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $5.8 → $7
Current: $2.30
Upside: +204.35%
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $3.28
Upside: +89.02%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.67
Upside: +281.47%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.27
Upside: +6,516.23%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $7.21
Upside: +37,347.99%